Today: 18 November 2025
Subscribe
Browse Category

Mergers & Acquisitions News 16 October 2025 - 22 October 2025

Warner Bros Discovery Stock Skyrockets on $60B Takeover Rumors

Warner Bros Discovery Stock Skyrockets on $60B Takeover Rumors

Shares Surge Amid Takeover Buzz On Oct. 21, Warner Bros Discovery officially confirmed that it was exploring “strategic alternatives” after fielding takeover inquiries theguardian.com reuters.com. In a press release, WBD said it had received “unsolicited interest…from multiple parties for both the entire company and Warner Bros.” theguardian.com. The news ignited a buying frenzy: WBD stock jumped from around $18.30 before the announcement to about $20 by the day’s end ts2.tech reuters.com. In dollar terms that was roughly an 11% one-day gain reuters.com, adding to an already massive rally this year (shares are up roughly 75% since Jan. 1 ts2.tech). The
22 October 2025
 ·  ·  ·  ·  · 
Media Shakeup: Warner Bros. Discovery Mulls Sale After Blockbuster Bids

Media Shakeup: Warner Bros. Discovery Mulls Sale After Blockbuster Bids

Sources: Official Warner Bros. Discovery press release prnewswire.com prnewswire.com; Reuters news reports reuters.com reuters.com; financial media (Investing.com, MarketScreener) investing.com marketscreener.com; and analysis (TechStock²) ts2.tech ts2.tech. Analyst consensus data from MarketBeat marketbeat.com.
21 October 2025
 ·  ·  ·  ·  · 
Blackstone & TPG in $18B Hologic Takeover Shock – Women’s Health Stock Skyrockets

Blackstone & TPG in $18B Hologic Takeover Shock – Women’s Health Stock Skyrockets

Deal Details and Company Background Hologic (NYSE: HOLX) is a Marlborough, MA–based medical technology firm focused on women’s health. Its products include mammography and breast biopsy systems, cervical cancer tests, surgical equipment (notably after its acquisition of Gynesonics), and lab diagnostics including molecular tests for Covid-19 bostonglobe.com. The Blackstone/TPG consortium will buy all outstanding Hologic shares for $76 cash plus a $3 CVR (contingent on hitting revenue goals in 2026–27 for the breast health business) marketscreener.com. This values the deal at $79 per share maximum and around $18.3 billion total enterprise value marketscreener.com. The purchase price represents a roughly 46%
21 October 2025
 ·  ·  ·  ·  ·  ·  · 
AlphaVest (ATMV) Rockets on AMC Robotics Merger Buzz – Key Facts & Forecast

AlphaVest (ATMV) Rockets on AMC Robotics Merger Buzz – Key Facts & Forecast

SPAC Structure and Acquisition Target AlphaVest Acquisition Corp is a special-purpose acquisition company (SPAC) – a “blank check” issuer that raised capital through an IPO to merge with a private company stockanalysis.com globenewswire.com. It has no business operations of its own; its entire asset is cash held in a trust. SPAC shareholders typically get stock in the merged company or can redeem their shares for cash (the trust value) if the deal fails. AlphaVest’s announced target is AMC Corporation, a Washington-based technology company specializing in AI-driven security and safety solutions marketscreener.com. AMC has developed products like YI-brand smart cameras and
21 October 2025
 ·  ·  ·  ·  ·  · 
DocGo (NASDAQ: DCGO) Stock Rockets After Virtual Care Acquisition – Can the Rally Last?

DocGo (NASDAQ: DCGO) Stock Rockets After Virtual Care Acquisition – Can the Rally Last?

Stock Surges on SteadyMD Acquisition DocGo’s shares jumped more than 34% in after-hours trading on Oct. 20, 2025, after the company announced it would acquire SteadyMD, a virtual care platform. According to an Investing.com report, DocGo stock “surged 34.6% in after-hours trading Monday following the company’s announcement that it has acquired virtual care platform SteadyMD” m.uk.investing.com. The acquisition was disclosed on Monday, Oct. 20, and a conference call to discuss it was scheduled for Oct. 21. SteadyMD brings a nationwide telehealth network (600+ clinicians serving ~3 million patients in 2025) to DocGo’s existing mobile health and ambulance services citybiz.co m.uk.investing.com.
21 October 2025
 ·  ·  ·  ·  · 
Sirius XM Stock Shocks Wall Street: Buffett’s Big Bet, Liberty Merger Fallout & 2025 Streaming Showdown

Sirius XM Stock Shocks Wall Street: Buffett’s Big Bet, Liberty Merger Fallout & 2025 Streaming Showdown

Bottom Line: Sirius XM Holdings stands at a crossroads in late 2025. The stock is cheap by the numbers (single-digit P/E, hefty dividend) nasdaq.com stockinvest.us and now free from Liberty’s tangle, it’s attracting big-name investors who see value. Upcoming earnings and guidance will be crucial in determining if Sirius XM can deliver growth or if it remains a cash cow in slow decline. With a 37% Buffett endorsement on one hand and Spotify-led disruption on the other, Sirius XM has become a fascinating battleground. Investors should watch subscriber trends, new product uptake, and management’s strategic pivots in the streaming era.
20 October 2025
 ·  ·  ·  ·  · 
Biotech Breakthrough: Rani Therapeutics (RANI) Stock Skyrockets on $1B Deal – What Investors Need to Know

Rani Therapeutics (RANI) Stock Nearly Triples on $1B Chugai Deal – What Investors Should Know

Key Facts – October 18, 2025 RANI Stock Price Explodes on Deal News Rani Therapeutics’ stock price erupted on Friday, Oct. 17, 2025, after the company unveiled its game-changing pharma partnership and a significant financing boost. In pre-market trading, RANI shares jumped over +150%, and the rally continued after the opening bell ts2.tech ts2.tech. The stock — which had closed at just $0.47 the day before — briefly hit about $1.37 intraday (nearly a 3× gain) on extremely heavy volume ts2.tech ts2.tech. By midday, RANI was still trading around $1.30, up ~180% on the day, marking a stunning one-day surge
18 October 2025
 ·  ·  ·  ·  · 
BBVA Stock Jumps on Failed Takeover Bid – What’s Next for the Banking Giant?

BBVA Stock Soars on Failed Sabadell Takeover Bid – Analysts See Upside Ahead

BBVA Shares Jump as Takeover Bid Collapses Madrid, October 17, 2025 – Banco Bilbao Vizcaya Argentaria (BBVA) stock jumped sharply on Friday after the Spanish banking giant’s hostile bid for Banco Sabadell fell through. BBVA shares rose about 5–7% in Madrid trading, closing near €16.8 (up roughly 6.9% on the day) investing.com reuters.com, while Sabadell’s stock plunged over 6% reuters.com. The rally came as BBVA announced it would immediately restart share buybacks – buying back €1 billion of its own shares starting October 31 – now that the Sabadell deal is off the table ts2.tech. BBVA also declared its largest-ever interim
17 October 2025
 ·  ·  ·  ·  ·  · 
GitLab Stock Rockets 11% on Datadog Buyout Buzz – AI Moves and Analyst Reactions

GitLab Stock Rockets 11% on Datadog Buyout Buzz – AI Moves and Analyst Reactions

GitLab Shares Surge on Takeover Speculation GitLab Inc.’s stock skyrocketed on October 16 following fresh buyout rumors. Shares jumped 10.6% intraday – from the mid-$40s to a $48.27 close – after a report that cloud-monitoring firm Datadog (DDOG) may be preparing a takeover bid ts2.tech. The rumored offer, above $60 per share, represents a hefty premium. Traders leapt at the news: GTLB’s ~11% one-day gain far outpaced the broader market, and volume exploded to ~19 million shares (about seven times the usual daily average) ts2.tech. The Datadog-GitLab chatter originated with a StreetInsider report and quickly spread on trading desks. According
17 October 2025
 ·  ·  ·  ·  · 
GitLab Stock Soars 11% on Datadog Takeover Rumors Amid AI DevOps Boom

GitLab Stock Soars 11% on Datadog Takeover Rumors Amid AI DevOps Boom

GitLab Shares Surge on Takeover Speculation GitLab Inc. (NASDAQ: GTLB) rocketed higher on Thursday amid renewed buyout speculation. The stock surged 10.6% intraday – rising from the mid-$40s to close at $48.27 – after a report that cloud-monitoring firm Datadog (DDOG) may be preparing a takeover bid seekingalpha.com. The rumored offer price, over $60 per share, represents a substantial premium. Traders responded enthusiastically to the prospect: GitLab’s nearly 11% one-day jump far outpaced the broader market, and trading volume exploded to ~19 million shares, about seven times its recent daily average stockanalysis.com stockanalysis.com. The Datadog-GitLab chatter first surfaced via a
17 October 2025
 ·  ·  ·  ·  · 
CSX CEO Abruptly Departs Amid Rail Merger Frenzy – What’s Next?

CSX Delivers Earnings Surprise: Stock Jumps as New CEO Navigates Rail Merger Frenzy

Earnings Beat Lifts CSX Stock CSX Corporation (NASDAQ: CSX) delivered stronger-than-expected third quarter results, boosting its stock price in recent trading. Shares of the Jacksonville-based freight railroad rose about 2–3% in after-hours trading following the earnings announcement reuters.com. CSX reported Q3 2025 net earnings of $694 million (or $0.37 per share) and an adjusted profit of $0.44 per share, which edged past consensus estimates of roughly $0.42 timesunion.com reuters.com. This positive earnings surprise, albeit modest, encouraged investors and helped lift the stock toward the upper-$30s. Revenue for the quarter came in at $3.59 billion, essentially flat (down 1% year-over-year) and roughly meeting
17 October 2025
 ·  ·  ·  ·  ·  ·  · 
BBVA Stock Jumps on Failed Takeover Bid – What’s Next for the Banking Giant?

BBVA Stock Jumps on Failed Takeover Bid – What’s Next for the Banking Giant?

BBVA Stock on the Rise – Recent Performance BBVA’s stock has been on a volatile upswing, with investors closely tracking every development. As of October 16, BBVA shares trade around €15.72 on the Spanish exchange, roughly 0.4% lower on the day investing.com. This slight dip followed a 1.3% drop on Oct. 15 investing.com, which erased gains from earlier in the week. Even so, the stock remains near multi-year highs after a strong rally in recent months. The bank’s U.S.-listed ADR (NYSE: BBVA) closed Oct. 16 at $19.48, leaping about 6.7% from the prior day investing.com. That dramatic one-day jump in
16 October 2025
 ·  ·  ·  ·  · 
1 … 6 7 8 9 10 … 12
Go toTop